ucsf banner
Helen Diller Family Compr Cancer Ctr
THOMAS G. MARTIN, MD

Associate Clinical Professor of Medicine, UCSF

CONTACT

(415) 353-2421 (appts)
(415) 353-2467 (fax)

Box 0324, UCSF; San Francisco, CA 94143-0324

additional websites:

UCSF Physician Referral Directory
EDUCATION

Cornell University, B.A., 1985, Genetics
University of Connecticut School of Medicine, M.D., 1989, Medicine
Harbor-UCLA Medical Center, 1992, Internal Medicine
University of California, San Francisco, 1996, Hematology and Oncology

PROFESSIONAL EXPERIENCE

1996-1999

Assistant Adjunct Professor, Hematology, Oncology and Bone Marrow Transplant, University of California San Francisco, San Francisco, CA

1999-2001

Assistant Professor of Medicine, Department of Blood and Marrow Transplantation, Division of Medicine, University of Texas M. D. Anderson Cancer Center, Houston, TX

2001-2003

Director, Matched Unrelated Donor Program, Adult Leukemia and Bone Marrow Transplantation, University of California, CA

2003

Associate Director, Hematology/Oncology Fellowship Program, Division of Hematology/Oncology, University of California, San Francisco, CA.

2004

Director, Myeloma Clinic, Adult Ambulatory Care Clinic, University of California, San Francisco, CA.

HONORS & AWARDS

1984

Cornell Tradition Fellow Award

1989

LANGE Book Award for Scholarship in Internal Medicine, University of Connecticut, Farmington, CT

2003

Faculty Teaching Award, Division of Hematology/Oncology, University of California, San Francisco, CA

SELECTED PUBLICATIONS

Malchoff CD, Javier EC, Malchoff DM, Martin T, et al: Primary Cortisol Resistance Presenting as Isosexual Precocity. Journal of Endocrinology and Metabolism. 70:2, 503-9, 1990.

Meng, YG, Martin T, Peterson ML, Shuman M, Cohen RL, Wong W: Circulating thrombopoietin concentrations in thrombocytopenic patients, including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. British Journal of Haematology. 95: 535-541, 1996

Martin TG, Somberg K, Cohen RL, Shuman MA, Meng YG: Thrombopoietin levels in cirrhotic patients before and after orthotopic liver transplantation. Annals of Internal Medicine. 127:4, 285-288, 1997.

Martin, TG and Shuman, M.A; Interferon-Induced Thrombocytopenia: Is It Time for Thrombopoietin? Hepatology. 28:5, 1430-1432, 1998.

Anderlini P, Donato M, Lauppe MJ, Huh YO, Martin TG, Chan KW, Champlin, RE, Korbling M; A comparative study of once-daily versus twice daily filgrastim administration for the mobilization and collection of CD34(+) peripheral blood progenitor cells in normal donors. British Journal of Hematology. 109, 770-772, 2000.

Martin, TG and Gajewski JA: Allogeneic Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America. 15:1 97-120, 2001.

Martin, TG and Linker, CA: Autologous Stem Cell Transplantation for Adults with Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America. 15:1 21- 143, 2001

Shimoni A, Gajewski J, Donato M, Martin T, O'Brien S, Huh V, Talpaz M, Cohen A, Korbling M, Champlin R, Giralt S: Long-Term Follow-up of Recipients of CD8-depleted Donor Lymphocyte Infusions fro the Treatment of Chronic Myelogenous Leukemia Relapsing After Allogeneic Progenitor Cell Transplantation. Biology of Blood and Marrow Transplantation. 7:568-575, 2001

Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Korbling M, Martin T, Ueno NT, Champlin RE, Khouri IF: Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Annals of Oncology. 13:450-459, 2002

Thall PF, Inoue LYT and Martin TG: Adaptive Decision Making in a Lymphocyte Infusion Trial. Biometrics. 58:560-568, 2002

Martin TG, Giralt S, Khouri I, Champlin RE: Non-Myeloablative Stem Cell Transplantation for Acute Myelogenous Leukemia. Acute Leukemias IX. Hematology and Blood Transfusion. 41:483-484, 2003

Gunn N, Damon L, Varosy P, Navarro W, Martin T, Reis C, Linker C. High CD34 Cell Dose Promotes Faster Platelet Recovery After Autologous Stem Cell Transplantation for Acute Myeloid Leukemia. Biol Blood Marrow Trasplant, 10:643-8, 2003

Wong R, Giralt SA, Martin T, Couriel DR, Anagnostopoulos A, Hosing C, Andersson BS, Cano P, Shahjahan M, Ippoliti C, Estey EH, McMannis J, Gajewski JL, Champlin RE, de Lima M: Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood. 102(8):3052-9, 2003

Khorshid O, de Meis E, Martin T, Jones RB, Shpall EJ, Nieto Y, Khouri I, Shahjahan M, Gajewski J, Giralt S, Champlin R, de Lima M: Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant. Leukemia. 17(12):2538-40, 2003

Couriel DR, Saliba R, Hicks K, Ippoliti C, De Lima MJ, Hosing C, Khouri I, Andersson B, Donato M, Gajewski J, Anderlini P, Kontoyiannis DP, Cohen A, Martin T, Giralt S, Champlin R: Tumor necrosis factor alpha blockade for the treatment of steroid-refractory acute GVHD. Blood (In press).

Martin TG, Thall PF, Giles FJ, Shahjahan M, deLima M, Couriel D, Champlin RE, Gajewski JA, Kantarjian HM, Andersson B, Giralt S: Allogeneic Stem Cell Transplantation in Individuals Pretreated with Gemtuzumab Ozogamicin (MylotargTM) During Anti-Leukemia Therapy: Incidence of VOD, Organ Toxicity and GVHD. Leuk & Lymph 2004 (submitted).

8/24/07

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.